other material
confidence high
sentiment positive
materiality 0.75
Tempus invests $36M in Personalis, exercises warrants and buys shares; expands commercial collaboration
Personalis, Inc.
- Tempus exercises warrants for 9.2M shares at avg $2.00 ($18.4M) and buys 3.5M shares at $5.07 ($17.7M).
- Total investment ~$36M; Tempus will own ~19.3% of Personalis outstanding common stock.
- Partners accelerate commercialization of ultra-sensitive MRD testing for breast, lung, and immunotherapy monitoring.
- Personalis to increase patient sample capacity; Tempus expands commercialization efforts over first two years.